BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37000113)

  • 41. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma.
    Ge D; Luo Z; Mao R; Zhao H; Lv X; Zhao J; Zhou J; Huang Z; Zhang Y; Li Z; Bi X; Cai J
    Adv Ther; 2020 Jul; 37(7):3185-3205. PubMed ID: 32436026
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic and prognostic nomograms for newly diagnosed intrahepatic cholangiocarcinoma with brain metastasis: A population-based analysis.
    Liu Z; Yi J; Yang J; Zhang X; Wang L; Liu S
    Exp Biol Med (Maywood); 2022 Sep; 247(18):1657-1669. PubMed ID: 35946168
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Simplified nomograms based on platelet-associated models for survival prediction in Asian hepatocellular carcinoma patients after surgery.
    Gu J; Zhang X; Wang Z; Cui R; Zhang J; Jia Y; Miao R; Fan H; Wang H; Li Y; Zhang J; Liu C; Qu K
    Surg Oncol; 2019 Sep; 30():131-138. PubMed ID: 31500777
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Web-Based Prediction Model for Cancer-Specific Survival of Elderly Patients With Early Hepatocellular Carcinoma: A Study Based on SEER Database.
    He T; Chen T; Liu X; Zhang B; Yue S; Cao J; Zhang G
    Front Public Health; 2021; 9():789026. PubMed ID: 35096742
    [No Abstract]   [Full Text] [Related]  

  • 45. Development and Validation of a Nomogram to Predict Cancer-Specific Survival for Middle-Aged Patients With Early-Stage Hepatocellular Carcinoma.
    Wen C; Tang J; Luo H
    Front Public Health; 2022; 10():848716. PubMed ID: 35296046
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic nomogram for colorectal cancer patients with multi-organ metastases: a Surveillance, Epidemiology, and End Results program database analysis.
    Tang X; Hu N; Huang S; Jiang J; Rao H; Yang X; Yuan Y; Zhang Y; Xia G
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12131-12143. PubMed ID: 37428251
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Construction and validation of a SEER-based prognostic nomogram for young and middle-aged males patients with hepatocellular carcinoma.
    Yang R; Yu X; Zeng P
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10099-10108. PubMed ID: 37266663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison and validation of the prognostic value of preoperative systemic immune cells in hepatocellular carcinoma after curative hepatectomy.
    Liao R; Peng C; Li M; Li DW; Jiang N; Li PZ; Ding X; Wu Q; Du CY; Gong JP
    Cancer Med; 2018 Apr; 7(4):1170-1182. PubMed ID: 29533004
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Construction and validation of a survival prognostic model for stage III hepatocellular carcinoma: a real-world, multicenter clinical study.
    Hao S; Luo R; Li W; Zhao R; Qi T; Wang Z; Li N; Liu M
    BMC Gastroenterol; 2023 Jun; 23(1):207. PubMed ID: 37312022
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and validation of a nomogram for survival prediction in hepatocellular carcinoma after partial hepatectomy.
    Lu Y; Ren S; Jiang J
    BMC Surg; 2023 Jan; 23(1):27. PubMed ID: 36717904
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel nomogram and risk classification system predicting the overall survival of patients with papillary renal cell carcinoma after nephrectomy: A population-based study.
    Hu Y; Xu S; Qi Q; Wang X; Meng J; Zhou J; Hao Z; Liang Q; Feng X; Liang C
    Front Public Health; 2022; 10():989566. PubMed ID: 36276376
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development and validation of a prognostic nomogram for adult patients with renal sarcoma: A retrospective study based on the SEER database.
    Zhu Y; Mao W; Zhang G; Sun S; Tao S; Jiang T; Wang Q; Meng Y; Wu J; Chen M
    Front Public Health; 2022; 10():942608. PubMed ID: 36187680
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Two Novel Nomograms Predicting the Risk and Prognosis of Pancreatic Cancer Patients With Lung Metastases: A Population-Based Study.
    Zhang W; Ji L; Zhong X; Zhu S; Zhang Y; Ge M; Kang Y; Bi Q
    Front Public Health; 2022; 10():884349. PubMed ID: 35712294
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A prognostic nomogram for stage II/III rectal cancer patients treated with neoadjuvant chemoradiotherapy followed by surgical resection.
    Lin Y
    BMC Surg; 2022 Jul; 22(1):256. PubMed ID: 35787802
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic nomograms and Aggtrmmns scoring system for predicting overall survival and cancer-specific survival of patients with kidney cancer.
    Zhou Y; Zhang R; Ding Y; Wang Z; Yang C; Tao S; Liang C
    Cancer Med; 2020 Apr; 9(8):2710-2722. PubMed ID: 32087609
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Prognostic Model for Patients With Gastric Signet Ring Cell Carcinoma.
    Guo Q; Wang Y; An J; Wang S; Dong X; Zhao H
    Technol Cancer Res Treat; 2021; 20():15330338211027912. PubMed ID: 34190015
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development and validation of a nomogram to predict survival outcome among epithelial ovarian cancer patients with site-distant metastases: a population-based study.
    Wang B; Wang S; Ren W
    BMC Cancer; 2021 May; 21(1):609. PubMed ID: 34034697
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nomogram Predicts Risk and Prognostic Factors for Bone Metastasis of Pancreatic Cancer: A Population-Based Analysis.
    Zhang W; Ji L; Wang X; Zhu S; Luo J; Zhang Y; Tong Y; Feng F; Kang Y; Bi Q
    Front Endocrinol (Lausanne); 2021; 12():752176. PubMed ID: 35356148
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nomograms to Predict the Disease-free Survival and Overall Survival after Radiofrequency Ablation for Hepatocellular Carcinoma.
    Takuma Y; Shota I; Miyatake H; Uematsu S; Okamoto R; Araki Y; Takabatake H; Morimoto Y; Yamamoto H
    Intern Med; 2018 Feb; 57(4):457-468. PubMed ID: 29151504
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation.
    Chai Y; Ma Y; Feng W; Lu H; Jin L
    World J Surg Oncol; 2021 Aug; 19(1):258. PubMed ID: 34461929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.